BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36874695)

  • 1. Factors Leading to Diagnostic and Therapeutic Delay of Rheumatoid Arthritis and Their Impact on Disease Outcome.
    Javaid U; Mahmud TH; Rasheed A; Javaid AUR; Riaz S; Zohaib A
    Cureus; 2023 Jan; 15(1):e34481. PubMed ID: 36874695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic delay in Rheumatoid Arthritis patients: Impact on disease outcome.
    Naeem F; Khan SEA; Saeed MA; Farman S
    Pak J Med Sci; 2021; 37(4):1001-1007. PubMed ID: 34290773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Hypothyroidism With Disease Activity Score-28 in Patients of Rheumatoid Arthritis.
    Zohaib A; Rasheed A; Mahmud TE; Hayat U; Shabbir S; Riaz S; Jamil MZZ; Javaid U
    Cureus; 2022 Jun; 14(6):e26382. PubMed ID: 35911270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
    Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
    Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients.
    Lee HJ; Pok LSL; Ng CM; Yahya F; Sockalingam S; Tee YC; Raja J
    Int J Rheum Dis; 2020 Aug; 23(8):1088-1093. PubMed ID: 32597545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
    Lutf A; Poil AR; Hammoudeh M
    Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.
    Miwa Y; Takahashi R; Ikari Y; Maeoka A; Nishimi S; Oguro N; Hayashi T; Hatano M; Isojima S; Yanai R; Kasama T; Toyoshima Y; Inagaki K; Sanada K
    Intern Med; 2017; 56(8):903-906. PubMed ID: 28420837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
    Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
    J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cyclic citrullinated peptide antibodies--activity markers in rheumatoid arthritis.
    Predeteanu D; Varzaru L; Balanescu A; Bojinca V; Opris D; Vlad V; Berghea F; Abobului M; Constantinescu C; Ionescu R
    J Med Life; 2009; 2(1):36-41. PubMed ID: 20108489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new 2010 ACR/EULAR criteria as predictor of clinical and radiographic response in patients with early arthritis.
    Mueller RB; Schiff M; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; von Kempis J;
    Clin Rheumatol; 2015 Jan; 34(1):51-9. PubMed ID: 25024096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
    Syngle A; Kaur S; Verma I; Syngle T; Syngle V
    Clin Rheumatol; 2017 Aug; 36(8):1715-1720. PubMed ID: 28634699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional disability associated with disease and quality-of-life parameters in Chinese patients with rheumatoid arthritis.
    Ji J; Zhang L; Zhang Q; Yin R; Fu T; Li L; Gu Z
    Health Qual Life Outcomes; 2017 May; 15(1):89. PubMed ID: 28464888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis.
    Iacovantuono M; Ferrigno S; Conigliaro P; Triggianese P; D'Antonio A; Spinelli FR; Bergamini A; Chimenti MS
    Reumatismo; 2024 Mar; 76(1):. PubMed ID: 38523584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed diagnosis and treatment of rheumatoid arthritis in Sarawak General Hospital.
    Wan SA; Teh CL; Cheong YK; Jobli AT
    Med J Malaysia; 2020 Mar; 75(2):141-145. PubMed ID: 32281595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is rheumatoid arthritis an innocent bystander in female reproductive problems? A comparative study of fertility in Nigerian women with and without rheumatoid arthritis.
    Akintayo RO; Aworinde OO; Ojo O; Akintayo FC; Akinlade OM; Awodun RO; Isa SO
    Eur J Rheumatol; 2018 Sep; 5(3):179-183. PubMed ID: 30185371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis.
    Liao KP; Batra KL; Chibnik L; Schur PH; Costenbader KH
    Ann Rheum Dis; 2008 Nov; 67(11):1557-61. PubMed ID: 18234714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.
    Aletaha D; Eberl G; Nell VP; Machold KP; Smolen JS
    Ann Rheum Dis; 2002 Jul; 61(7):630-4. PubMed ID: 12079906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.
    Miwa Y; Saito M; Furuya H; Yanai R; Ikari Y; Hayashi T; Kasama T; Toyoshima Y; Inagaki K
    Intern Med; 2017 Sep; 56(17):2271-2275. PubMed ID: 28794381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.